An adverse reaction to buprenorphine/naloxone induction in prison: A case report

Addictive Disorders and their Treatment

Volumn 10, Issue 4, 2011, Pages 199-200

  Rich, Josiah D ^a,b   McKenzie, Michelle ^a,b   Dickman, Samuel ^a,b   Bratberg, Jeffrey ^c   Lee, Joshua D ^d   Schwartz, Robert P ^e  

^a BROWN UNIVERSITY   (United States)

^b Center for Prisoner Health and Human Rights   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e FRIENDS RESEARCH INSTITUTE   (United States)

Author keywords

adverse event; naloxone; opiate addiction; prison; Words: buprenorphine

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE PLUS NALOXONE; OPIATE;

ADULT; ARTICLE; CASE REPORT; CYANOSIS; DRUG ACCUMULATION; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; FATIGUE; FEMALE; HUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PRISON; RELAPSE; RESIDENTIAL CARE; SIDE EFFECT; SLEEP AROUSAL DISORDER; VITAL SIGN;

EID: 81855194443     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e3182133949     Document Type: Article

References (8)

1. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison-a high risk of death for former inmates. N Engl J Med. 2007;356:157-165. (Pubitemid 46089676)
2. McKenzie M, Nunn A, Zaller ND, et al. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manag. 2009;5:219-227.
3. Nunn A, Zaller N, Dickman S, et al. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-88.
4. Zaller ND, Holmes L,Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19:522-531.
5. Magura S, Lee JD, Hershberger J, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99:222-230.
6. Suboxone (buprenorphine HCl and naloxone HCl dehydrate sublingual tablets) [package insert]. Richmond, VA: Reckitt Benckiser Pharmaceuticals Inc; 2006.
7. Lexi-Interact [computer program]. Hudson, OH: Lexi-Comp; 2009.
8. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004.